MYCN contributes to the sensitization of acute myelogenous leukemia cells to cisplatin by targeting SRY-box transcription factor 4
Little was known about the role of MYCN in drug resistance in acute myeloid leukemia (AML). We investigated impacts of MYCN on sensitization of AML cell to cisplatin, and its interaction with SRY-box transcription factor 4 (SOX4). In vitro, human AML cell lines HL60 and KG-1 were transfected with th...
Guardado en:
Autores principales: | Xianbao Huang, Ling Qi, Wei Lu, Ziye Li, Wuping Li, Fei Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f5f9fcbfe37a41d894aea6a42f012166 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
LINC00998 functions as a novel tumor suppressor in acute myeloid leukemia via regulating the ZFP36 ring finger protein/mammalian target of rapamycin complex 2 axis
por: Ximin Fang, et al.
Publicado: (2021) -
Mechanistic insights into the renoprotective role of curcumin in cisplatin-induced acute kidney injury: network pharmacology analysis and experimental validation
por: Zhang Hui, et al.
Publicado: (2021) -
IRF2-INPP4B-mediated autophagy suppresses apoptosis in acute myeloid leukemia cells
por: Zhang,Feng, et al.
Publicado: (2019) -
MicroRNA miR-30a inhibits cisplatin resistance in ovarian cancer cells through autophagy
por: Yi Cai, et al.
Publicado: (2021) -
Expression characteristic of 4Ig B7-H3 and 2Ig B7-H3 in acute myeloid leukemia
por: Wei Zhang, et al.
Publicado: (2021)